Abstract 1847P
Background
With the increasing number of oncologic patients, consultation time per patient shortens, which negatively affects the doctor – patient relationship. Participation in psychotherapeutic groups can help patients gain trust in their treatment. The aim of this study is to quantify the effects of Simonton-training on the psychological state, quality of life and compliance in oncologic patients.
Methods
This survey was carried out at the University of Debrecen in the course of a 12-occasion-long Simonton training. A total of 27 patients in the psychotherapeutic group, and 63 patients in the control group were included in this study. Patients filled out an online questionnaire three times, before the training (t0), right after the training (t1), and again 3 months later (t2). The online questionnaire contained: The Hospital Anxiety and Depression Scale (HADS), WHO Quality of Life 5-item questionnaire (WHO QOL5), Morisky Medication Adherence Scale (MMAS-8) and five questions (5Q) about the general attitude towards their treatment and the trust in their oncologist. The distribution of continuous variables was statistically analysed with the Shapiro-Wilk test, and Wilcoxon test was used for comparisons between the case and control groups due to the non-normal distribution of the majority of variables.
Results
From t0 to t1, the Simonton group’s quality of life significantly increased (p=0,016), meanwhile the control group’s QoL didn’t change significantly (p=0,575). According to HADS scale, the Simonton group’s anxiety significantly decreased from t0 to t1 (p=0,0005), and the change of the control wasn’t significant (p=0,247). Depression values also showed a significant decrease for the Simonton group from t0 to t1 (p=0,003), whereas the control’s depression values didn’t change significantly (p=0,122). After psychotherapy, the Simonton group evaluated their therapy-related attitude better with the 5Q, than at t0 (p=0,026). During this time, the control’s value didn’t change significantly (p=0,532).
Conclusions
On the basis of this study the Simonton training had a positive impact on the patients' psychological state and their quality of life increased.
Clinical trial identification
DE RKEB/IKEB 5773-2021.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05